Market Place
Sourcing Support
All News #Library
Rare Diseases
Lexeo Therapeutics Advances FDA Talks For Accelerated Approval
07 Oct 2025 //
GLOBENEWSWIRE
FDA grants Breakthrough Therapy Designation to Lexeo`s LX2006
07 Jul 2025 //
GLOBENEWSWIRE
Lexeo Reports Positive Ph1/2 Data for LX2006 in FA-Cardiomyopathy
07 Apr 2025 //
GLOBENEWSWIRE
Lexeo Announces Positive Interim Data For Friedreich Ataxia Treatment
15 Jul 2024 //
GLOBENEWSWIRE
Lexeo Granted FDA Fast Track Designation and Orphan Drug Designation for LX2020
18 Dec 2023 //
GLOBENEWSWIRE
Lexeo Receives Rare Pediatric Disease & Orphan Drug Designation for LX2006
30 Jun 2021 //
GLOBENEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.